header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-180305-9
Fish name: cyp2r1ihb153/ihb153
Genotype: cyp2r1ihb153/ihb153
Targeting Reagent: none
HUMAN DISEASE MODELED by cyp2r1ihb153/ihb153
No data available
GENE EXPRESSION
Gene expression in cyp2r1ihb153/ihb153
RNA expression
Expressed Gene Structure Conditions Figures
cyp2r1 standard conditions Fig. 2 with image from Peng et al., 2017
cyp24a1 standard conditions Fig. S2 with image from Peng et al., 2017
cyp27a1.4 standard conditions Fig. S2 with image from Peng et al., 2017
cyp27b1 standard conditions Fig. S2 with image from Peng et al., 2017
esrra control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
gh1 standard conditions Fig. S5 from Peng et al., 2017
ghra standard conditions Fig. S5 from Peng et al., 2017
igf1 standard conditions Fig. S5 from Peng et al., 2017
mcu control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
mrpl2 control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
mrpl15 control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
mrps10 control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
mtfp1 control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
nrf1 control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
pparg control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
ppargc1a standard conditions Fig. 5 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 5 from Peng et al., 2017
slc25a20 control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
ucp1 control Fig. 6 from Peng et al., 2017
chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
Reporter gene expression No data available
PHENOTYPE
Phenotype in cyp2r1ihb153/ihb153
Phenotype Conditions Figures
adipose tissue increased amount, abnormal fasting Fig. S4 with image from Peng et al., 2017
blood plasma calcium(2+) amount, normal standard conditions Fig. S2 with image from Peng et al., 2017
blood plasma D3 vitamins decreased amount, abnormal standard conditions Table 1 from Peng et al., 2017
blood plasma fatty acid increased amount, abnormal fasting Table 1 from Peng et al., 2017
blood plasma fatty acid increased amount, abnormal standard conditions Table 1 from Peng et al., 2017
blood plasma phosphorus(1+) amount, normal standard conditions Fig. S2 with image from Peng et al., 2017
bone element morphology, normal standard conditions Fig. S2 with image from Peng et al., 2017
cartilage element morphology, normal standard conditions Fig. S2 with image from Peng et al., 2017
female organism lipid increased amount, abnormal standard conditions Fig. 3 with image from Peng et al., 2017
hypophysis gh1 expression increased amount, abnormal standard conditions Fig. S5 from Peng et al., 2017
lipid metabolic process decreased process quality, abnormal fasting Fig. S4 with image from Peng et al., 2017
liver cyp24a1 expression decreased amount, abnormal standard conditions Fig. S2 with image from Peng et al., 2017
liver ab3-stat5 labeling decreased amount, abnormal standard conditions Fig. S5 from Peng et al., 2017
liver cyp27b1 expression increased amount, abnormal standard conditions Fig. S2 with image from Peng et al., 2017
liver Ab1-ppargc1a labeling increased amount, abnormal standard conditions Fig. S6 from Peng et al., 2017
liver Ab1-mt-co1 labeling increased amount, abnormal standard conditions Fig. S7 from Peng et al., 2017
liver ghra expression increased amount, abnormal standard conditions Fig. S5 from Peng et al., 2017
liver cyp2r1 expression increased amount, abnormal standard conditions Fig. 2 with image from Peng et al., 2017
liver Ab3-cox4 labeling increased amount, abnormal standard conditions Fig. S7 from Peng et al., 2017
liver igf1 expression increased amount, abnormal standard conditions Fig. S5 from Peng et al., 2017
liver cyp27a1.4 expression increased amount, abnormal standard conditions Fig. S2 with image from Peng et al., 2017
liver D3 vitamins decreased amount, abnormal standard conditions Table 1 from Peng et al., 2017
liver mitochondrion amount, normal standard conditions Fig. S7 from Peng et al., 2017
liver mitochondrion functionality, normal standard conditions Fig. S7 from Peng et al., 2017
liver triglyceride amount, normal standard conditions Fig. S3 from Peng et al., 2017
male organism lipid increased amount, abnormal standard conditions Fig. 3 with image from Peng et al., 2017
pleuroperitoneal cavity fat cell increased amount, abnormal standard conditions Fig. 3 with image from Peng et al., 2017
subcutaneous fat increased amount, abnormal standard conditions Fig. 3 with image from Peng et al., 2017
visceral fat ucp1 expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat ppargc1a expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 5 from Peng et al., 2017
visceral fat nrf1 expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat pparg expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat mtfp1 expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat Ab1-ppargc1a labeling amount, ameliorated chemical treatment by environment: calcidiol Fig. 5 from Peng et al., 2017
visceral fat mrpl15 expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat mrps10 expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat mcu expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat slc25a20 expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat esrra expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat mrpl2 expression amount, ameliorated chemical treatment by environment: calcidiol Fig. 6 from Peng et al., 2017
visceral fat mtfp1 expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat nrf1 expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat Ab3-cox4 labeling decreased amount, abnormal standard conditions Fig. 6 from Peng et al., 2017
visceral fat esrra expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat mcu expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat Ab1-ppargc1a labeling decreased amount, abnormal standard conditions Fig. 5 from Peng et al., 2017
visceral fat mrps10 expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat ppargc1a expression decreased amount, abnormal standard conditions Fig. 5 from Peng et al., 2017
visceral fat slc25a20 expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat ucp1 expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat mrpl2 expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat mrpl15 expression decreased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat Ab1-mt-co1 labeling decreased amount, abnormal standard conditions Fig. 6 from Peng et al., 2017
visceral fat ghra expression increased amount, abnormal standard conditions Fig. S5 from Peng et al., 2017
visceral fat pparg expression increased amount, abnormal control Fig. 6 from Peng et al., 2017
visceral fat increased amount, abnormal standard conditions Fig. 3 with image from Peng et al., 2017
visceral fat igf1 expression increased amount, abnormal standard conditions Fig. S5 from Peng et al., 2017
visceral fat D3 vitamins decreased amount, abnormal standard conditions Table 1 from Peng et al., 2017
visceral fat mitochondrion decreased amount, abnormal standard conditions Fig. 6 from Peng et al., 2017
visceral fat mitochondrion decreased functionality, abnormal standard conditions Fig. 6 from Peng et al., 2017
visceral fat mitochondrion membrane potential, abnormal standard conditions Fig. 6 from Peng et al., 2017
whole organism decreased length, abnormal standard conditions Fig. 4 with imageTable S1 from Peng et al., 2017
whole organism decreased size, abnormal standard conditions Fig. 2 with image from Peng et al., 2017
whole organism decreased weight, abnormal standard conditions Fig. 4 with imageTable S1 from Peng et al., 2017
whole organism length, ameliorated chemical treatment by environment: calcidiol Fig. 4 with image from Peng et al., 2017
whole organism morphology, normal standard conditions Fig. 2 with image from Peng et al., 2017
whole organism viability, normal standard conditions Table S1 from Peng et al., 2017
whole organism weight, ameliorated chemical treatment by environment: calcidiol Fig. 4 with image from Peng et al., 2017
whole organism lipid amount, ameliorated chemical treatment by environment: calcidiol Fig. 4 with image from Peng et al., 2017
whole organism lipid increased amount, abnormal standard conditions Fig. 4 with image from Peng et al., 2017

CITATIONS  (1)